Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets

David S. Johnson(Stanford Medicine), Wei Li(Baylor College of Medicine), D. Benjamin Gordon(Agilent Technologies (United States)), Arindam Bhattacharjee(Agilent Technologies (United States)), Bo Curry(Agilent Technologies (United States)), Jayati Ghosh(Agilent Technologies (United States)), Leonardo Brizuela(Agilent Technologies (United States)), Jason S. Carroll(Cancer Research UK), Myles Brown(Harvard University), Paul Flicek(European Bioinformatics Institute), Christof Koch(European Bioinformatics Institute), Ian Dunham(European Bioinformatics Institute), Mark Bieda(University of California, Davis), Xiaoqin Xu(University of California, Davis), Peggy Farnham(University of California, Davis), Philipp Kapranov, David A. Nix(University of Utah), T Gingeras, Xinmin Zhang(Roche (Switzerland)), H. Holster(Roche (Switzerland)), Nan Jiang(Roche (Switzerland)), Roland D. Green(Roche (Switzerland)), Jun S. Song(Harvard University Press), Scott McCuine(Whitehead Institute for Biomedical Research), Elizabeth D. Anton(Stanford University), Loan Nguyen(Stanford University), Nathan D. Trinklein(Children's Cancer Center), Zhen Ye(Ludwig Cancer Research), Keith A. Ching(Ludwig Cancer Research), David Hawkins(Ludwig Cancer Research), Bing Ren(Ludwig Cancer Research), Peter C. Scacheri(Case Western Reserve University), Joel Rozowsky(Yale University), Alexander Karpikov(Yale University), Ghia Euskirchen(Yale University), Sherman M. Weissman(Yale University), Mark Gerstein(Yale University), M Snyder(Yale University), Annie Yang(Acentech (United States)), Zarmik Moqtaderi(Harvard University), Heather A. Hirsch(Harvard University), Hennady P. Shulha(Boston University), Yutao Fu(Boston University), Zhiping Weng(Boston University), Kevin Struhl(Harvard University), R Myers(Stanford University), Jason D. Lieb(University of North Carolina at Chapel Hill), X. Shirley Liu(Harvard University Press)
Genome Research
February 7, 2008
Cited by 129Open Access
Full Text

Abstract

The most widely used method for detecting genome-wide protein-DNA interactions is chromatin immunoprecipitation on tiling microarrays, commonly known as ChIP-chip. Here, we conducted the first objective analysis of tiling array platforms, amplification procedures, and signal detection algorithms in a simulated ChIP-chip experiment. Mixtures of human genomic DNA and "spike-ins" comprised of nearly 100 human sequences at various concentrations were hybridized to four tiling array platforms by eight independent groups. Blind to the number of spike-ins, their locations, and the range of concentrations, each group made predictions of the spike-in locations. We found that microarray platform choice is not the primary determinant of overall performance. In fact, variation in performance between labs, protocols, and algorithms within the same array platform was greater than the variation in performance between array platforms. However, each array platform had unique performance characteristics that varied with tiling resolution and the number of replicates, which have implications for cost versus detection power. Long oligonucleotide arrays were slightly more sensitive at detecting very low enrichment. On all platforms, simple sequence repeats and genome redundancy tended to result in false positives. LM-PCR and WGA, the most popular sample amplification techniques, reproduced relative enrichment levels with high fidelity. Performance among signal detection algorithms was heavily dependent on array platform. The spike-in DNA samples and the data presented here provide a stable benchmark against which future ChIP platforms, protocol improvements, and analysis methods can be evaluated.


Related Papers

No related papers found

Powered by citation graph analysis